1. Home
  2. FBIN vs KYMR Comparison

FBIN vs KYMR Comparison

Compare FBIN & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

HOLD

Current Price

$37.74

Market Cap

6.2B

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$85.50

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIN
KYMR
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.8B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
FBIN
KYMR
Price
$37.74
$85.50
Analyst Decision
Buy
Strong Buy
Analyst Count
11
26
Target Price
$61.40
$107.72
AVG Volume (30 Days)
3.4M
575.0K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.76%
N/A
EPS Growth
N/A
N/A
EPS
2.47
N/A
Revenue
$4,463,200,000.00
$39,211,000.00
Revenue This Year
$2.75
$11.85
Revenue Next Year
$3.64
$7.79
P/E Ratio
$15.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.07
$19.45
52 Week High
$64.84
$103.00

Technical Indicators

Market Signals
Indicator
FBIN
KYMR
Relative Strength Index (RSI) 29.66 58.07
Support Level N/A $77.78
Resistance Level $53.30 $95.90
Average True Range (ATR) 1.86 3.82
MACD 0.19 0.78
Stochastic Oscillator 18.98 88.79

Price Performance

Historical Comparison
FBIN
KYMR

About FBIN Fortune Brands Innovations Inc.

Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: